Century Therapeutics annual capital expenditures (capex)
2020
2021
2022
2023
2024
2025
Century Therapeutics Capital Expenditures (CapEx) Growth & History (IPSC)
Century Therapeutics's capital expenditures (capex) was $848,000 for fiscal 2025.
View full Century Therapeutics company overviewCentury Therapeutics annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $848,000 | $694,000 | +450.65% |
| 2024 | 2024-12-31 | $154,000 | −$13.6M | −98.88% |
| 2023 | 2023-12-31 | $13.7M | −$16.9M | −55.12% |
| 2022 | 2022-12-31 | $30.6M | −$14.4M | −31.95% |
| 2021 | 2021-12-31 | $45.0M | $35.1M | +357.71% |
| 2020 | 2020-12-31 | $9.8M | — | — |
Century Therapeutics quarterly capital expenditures (capex)
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $694,000 | $377,000 | +118.93% |
| Q1 2026 | 2026-03-31 | $584,000 | $109,000 | +22.95% |
| Q4 2025 | 2025-12-31 | $139,000 | — | — |
| Q3 2025 | 2025-09-30 | $195,000 | — | — |
| Q2 2025 | 2025-06-30 | $317,000 | $52,000 | +19.62% |
| Q1 2025 | 2025-03-31 | $475,000 | −$64,000 | −11.87% |
| Q2 2024 | 2024-06-30 | $265,000 | −$4.2M | −94.11% |
| Q1 2024 | 2024-03-31 | $539,000 | −$4.5M | −89.20% |
| Q4 2023 | 2023-12-31 | $980,000 | −$5.3M | −84.37% |
| Q3 2023 | 2023-09-30 | $3.3M | −$6.5M | −66.72% |
| Q2 2023 | 2023-06-30 | $4.5M | −$6.0M | −56.97% |
| Q1 2023 | 2023-03-31 | $5.0M | $924,000 | +22.72% |
| Q4 2022 | 2022-12-31 | $6.3M | −$10.5M | −62.51% |
| Q3 2022 | 2022-09-30 | $9.8M | −$5.9M | −37.65% |
| Q2 2022 | 2022-06-30 | $10.5M | −$172,000 | −1.62% |
| Q1 2022 | 2022-03-31 | $4.1M | $2.2M | +115.87% |
| Q4 2021 | 2021-12-31 | $16.7M | — | — |
| Q3 2021 | 2021-09-30 | $15.7M | $11.2M | +249.22% |
| Q2 2021 | 2021-06-30 | $10.6M | — | — |
| Q1 2021 | 2021-03-31 | $1.9M | — | — |
| Q3 2020 | 2020-09-30 | $4.5M | — | — |
Century Therapeutics capital expenditures (capex) trends
Over the last five fiscal years, Century Therapeutics's capital expenditures (capex) decreased from $9.8M to $848,000, a change of −$9.0M. The latest reported quarter, Q2 2026, shows $694,000.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Century Therapeutics source filings ↗